University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

Spicer, J, Plunkett, T, Somaiah, N, Chan, S, Kendall, A, Bolunwu, N and Pandha, H (2005) Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer PROSTATE CANCER AND PROSTATIC DISEASES, 8 (4). pp. 364-368.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Spicer, JUNSPECIFIEDUNSPECIFIED
Plunkett, TUNSPECIFIEDUNSPECIFIED
Somaiah, NUNSPECIFIEDUNSPECIFIED
Chan, SUNSPECIFIEDUNSPECIFIED
Kendall, AUNSPECIFIEDUNSPECIFIED
Bolunwu, NUNSPECIFIEDUNSPECIFIED
Pandha, Hh.pandha@surrey.ac.ukUNSPECIFIED
Date : 1 December 2005
Identification Number : 10.1038/sj.pcan.4500821
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, Urology & Nephrology, ONCOLOGY, UROLOGY & NEPHROLOGY, capecitabine, chemotherapy, PSA, FLUOROURACIL PLUS LEUCOVORIN, METASTATIC COLORECTAL-CANCER, INTRAVENOUS FLUOROURACIL, BREAST-CANCER, FOLINIC ACID, 5-FLUOROURACIL, TRIAL, MITOXANTRONE, THERAPY, PREDNISONE
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:31
Last Modified : 17 May 2017 14:43
URI: http://epubs.surrey.ac.uk/id/eprint/824024

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800